FinTrust Capital Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-595
| Closed | -$50.9K | – | 1263 |
|
|
2023
Q4 | $50.9K | Buy |
595
+5
| +0.8% | +$428 | 0.01% | 474 |
|
|
2023
Q3 | $52.9K | Sell |
590
-159
| -21% | -$14.2K | 0.01% | 443 |
|
|
2023
Q2 | $58.9K | Sell |
749
-2,000
| -73% | -$157K | 0.01% | 420 |
|
|
2023
Q1 | $224K | Hold |
2,749
| – | – | 0.05% | 245 |
|
|
2022
Q4 | $216K | Buy |
2,749
+2,000
| +267% | +$157K | 0.05% | 253 |
|
|
2022
Q3 | $60K | Buy |
+749
| New | +$60K | 0.02% | 472 |
|
|
2021
Q2 | – | Sell |
-25
| Closed | -$3K | – | 1177 |
|
|
2021
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 1053 |
|
|
2020
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 981 |
|
|
2020
Q3 | $2 | Hold |
25
| – | – | ﹤0.01% | 1054 |
|
|
2020
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 916 |
|
|
2020
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 995 |
|
|
2019
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 931 |
|
|
2019
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 921 |
|
|
2019
Q2 | $3K | Hold |
25
| – | – | ﹤0.01% | 899 |
|
|
2019
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 1087 |
|
|
2018
Q4 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 1030 |
|